This year’s top stories in biomedicine bring science and social values head-to-head: Multiple teams this year announced that they had used CRISPR/CAS9 gene editing technology to modify human embryos. Although some of the claims about efficiency and accuracy are under debate, the research community is undeniably moving ahead with controversial work that even many fellow scientists say should be subject to better rules and regulations than currently exist.